Is Exponent, Inc. (EXPO) A Good Stock To Buy Now?
Is EXPO a good stock to buy? We came across a bullish thesis on Exponent, Inc. on X.com by @tomicki. In this article, we will summarize the bulls’ thesis on EXPO.
Exponent Inc (EXPO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,323,097 | $77,745,180 | +16% | 0.63% |
| 2. | AQR Capital Management Cliff Asness | 1,144,847 | $67,271,185 | +17% | 0.02% |
| 3. | Point72 Asset Management Steve Cohen | 394,502 | $23,180,938 | 0.03% | |
| 4. | Millennium Management Israel Englander | 391,047 | $22,977,922 | -25% | 0.01% |
| 5. | BAMCO Inc. Ron Baron | 364,297 | $21,406,092 | -27% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $68.45 | 184 | $12,593.92 | 40,873 | 2026-09-18 | Filing | |
| $66.64 | 89 | $5,931.18 | 29,581 | 2026-01-02 | Filing | |
| $63.75 | 80 | $5,099.60 | 29,492 | 2025-10-03 | Filing | |
| $73.25 | 80 | $5,859.60 | 29,412 | 2025-07-04 | Filing | |
| $73.21 | 67 | $4,904.87 | 31,332 | 2025-04-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.28 | 1,707 | $113,135.86 | 129,108 | 2026-08-17 | Filing | |
| $62.78 | 1,737 | $109,044.69 | 115,771 | 2026-07-15 | Filing | |
| $57.13 | 1,793 | $102,427.46 | 107,257 | 2026-06-15 | Filing | |
| $57.13 | 2,326 | $132,875.77 | 106,670 | 2026-06-15 | Filing | |
| $57.47 | 2,000 | $114,930.00 | 1,105 | 2026-05-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 265,398 | $17,362,337 | 0.38% | |
| 2. | 3,432 | $224,521 | 0.01% | |
| 3. | 3,099 | $202,737 | 0.01% | |
| 4. | 959 | $62,730 | 0% | |
| 5. | 900 | $58,878 | 0.01% |
News See All
Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript February 5, 2026Exponent, Inc. beats earnings expectations. Reported EPS is $0.4893, expectations were $0.47.
Exponent, Inc. (NASDAQ:EXPO) Q1 2026 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO) Q1 2026 Earnings Call Transcript February 5, 2026Exponent, Inc. beats earnings expectations. Reported EPS is $0.4893, expectations were $0.47. Operator: Good afternoon.
Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90
Exponent, Inc. (NASDAQ:EXPO) is included among the 15 Overlooked Dividend Stocks to Buy Right Now. On November 2, Truist lowered its price target for Exponent, Inc.
15 Overlooked Dividend Stocks to Buy Right Now
In this article, we will take a look at some of the best overlooked stocks to buy right now.
Exponent, Inc. (NASDAQ:EXPO) Q3 2025 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO) Q3 2025 Earnings Call Transcript October 30, 2025Exponent, Inc. beats earnings expectations. Reported EPS is $0.55, expectations were $0.5.
Exponent (EXPO) Tumbled as Guidance Fell Short of Expectations
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter.
What Makes Exponent (EXPO) a Compelling Short Opportunity?
Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here.
Exponent, Inc. (NASDAQ:EXPO) Q2 2025 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO) Q2 2025 Earnings Call Transcript August 1, 2025 Operator: Good day, and welcome to Exponent Second Quarter 2025 Earnings Conference Call.
Should You Hold Exponent (EXPO) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.